Canada Spends Logo

Explore our Budget 2026 analysis

Contribution: Substance Use and Addictions Program

Sts'ailes

$488,288.00

2223-HQ-000222

FY 2022-23 · 2023-03-15

Summary
To strengthen responses to drug and substance use issues in Canada.
Department
Program
Substance Use and Addictions ProgramSubstance Use and Addictions Program (linked with high confidence)
Recipient
Location
Agassiz, British Columbia, Canada
Recipient Type
Indigenous recipient
Business Number
106910995
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions

As published

Agreement End Date
2025-03-31
Agreement Number
2223-HQ-000222
Agreement Start Date
2023-03-15
Agreement Title
2223-HQ-000222
Agreement Title (French)
2223-HQ-000222
Agreement Type
Contribution
Agreement Value
$488,288.00
Amendment Number
0
Description
To strengthen responses to drug and substance use issues in Canada.
Description (French)
Renforcer les réponses aux problèmes de consommation de drogues et de substances au Canada.
Expected Results
Targeted stakeholders and Canadians access evidence-informed information related to substance use and are equipped with the capacity (knowledge, skills and supports) to inform their decisions and actions related to substance use.
Expected Results (French)
Les intervenants et les Canadiens ciblés ont accès à des renseignements fondés sur des données probantes concernant la consommation de substances et ont la capacité (connaissances, compétences et soutien) d’éclairer leurs décisions et actions en matière de consommation de substances.
Organization Code
hc-sc
Organization
Health Canada | Santé Canada
Program Name
Substance Use and Addictions Program
Program Name (French)
Programme sur l’usage et les dépendances aux substances
Program Purpose
Health Protection and Promotion
Program Purpose (French)
Protection et promotion de la santé
Recipient Business Number
106910995
Recipient City
Agassiz
Recipient Country
CA
Recipient Legal Name
Sts'ailes
Recipient Postal Code
V0M 1A1
Recipient Province or Territory
BC
Recipient Type
A
Reference Number
271-2022-2023-Q4-00120